TdC 261: Fibrilação atrial - Condutas no pronto-socorro

Ta de Clinicagem

Ciência Fitness Medicamento Ta De Clinicagem Raciocínio Diagnóstico Clinicagem Medicina

内容由Ta de Clinicagem提供。所有播客内容（包括剧集、图形和播客描述）均由 Ta de Clinicagem 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

28d ago 58:00

MP3•单集首页

Kaue Malpighi e Lucca Cirillo convidam Rafael Martins (@ecg_aulas) para conversar sobre manejo de fibrilação atrial no PS.

Referências:
1. Andrade, Jason G, and L Brent Mitchell. “Periprocedural Anticoagulation for Cardioversion of Acute Onset Atrial Fibrillation and Flutter: Evidence Base for Current Guidelines.” The Canadian journal of cardiology vol. 35,10 (2019): 1301-1310. doi:10.1016/j.cjca.2019.06.006
2. Palomäki, A., Mustonen, P., Hartikainen, J. E. K., Nuotio, I., Kiviniemi, T., Ylitalo, A., Hartikainen, P., Lehtola, H., Luite, R., & Airaksinen, K. E. J. (2016). Strokes after cardioversion of atrial fibrillation - The FibStroke study. International Journal of Cardiology, 203, 269–273. https://doi.org/10.1016/j.ijcard.2015.10.168
3. Joglar, José A et al. “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.” Circulation vol. 149,1 (2024): e1-e156. doi:10.1161/CIR.0000000000001193
4. Moran JL, Gallagher J, Peake SL, et al. Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study. Crit Care Med. 1995 Nov;23(11):1816-24. doi: 10.1097/00003246-199511000-00005
5. Slavik RS, Tisdale JE, Borzak S. Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence. Prog Cardiovasc Dis. 2001 Sep-Oct;44(2):121-52. doi: 10.1053/pcad.2001.26966
6. Davey MJ, Teubner D. A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation. Ann Emerg Med. 2005 Apr;45(4):347-53. doi: 10.1016/j.annemergmed.2004.09.013
7. Van Gelder IC, Groenveld HF, Crijns HJ, et al.; RACE II Investigators. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010 Apr 15;362(15):1363-73. doi: 10.1056/NEJMoa1001337
8. Wetterslev M, Haase N, Hassager C, et al. New-onset atrial fibrillation in adult critically ill patients: a scoping review. Intensive Care Med. 2019 Jul;45(7):928-938. doi: 10.1007/s00134-019-05633-x
9. O'Bryan LJ, Redfern OC, Bedford J, et al. Managing new-onset atrial fibrillation in critically ill patients: a systematic narrative review. BMJ Open. 2020 Mar 24;10(3):e034774. doi: 10.1136/bmjopen-2019-034774
10. Kirchhof P, Camm AJ, Goette A, et al. EAST-AFNET 4 Trial Investigators. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422